Sign in
Enrolling by invitationNo phase

Helping low-income adults with type 1 diabetes start continuous glucose monitoring

Tests a support program to help low-income adults with type 1 diabetes use glucose sensors.

Key facts

Who runs it
University of Connecticut
Where
Middletown and Vero Beach, United StatesSee the 2 sites
Trial code
Registry title
Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D
Status
Enrolling by invitation
People taking part
30 people, planned
Started
28 May 2024
Planned end
1 Aug 2026
Type of study
Interventional, 2 groups
Treatments tested
  • CGM Intervention
  • SMBG Control Condition
Record updated
12 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for low-income adults with type 1 diabetes who get care at a federally qualified health center. It tests ways to help them start using a continuous glucose monitor (CGM).

Age
18 years or older
Sex
All sexes can join
Disease stage
Documented diagnosis of type 1 diabetes (T1D)
Earlier treatment
If a person has used a CGM before or uses one now, they must report difficulty using it.

Main reasons for not taking part

  • Pregnancy or planning to become pregnant
  • Breastfeeding (lactation)
  • Serious illness that may prevent taking part (for example severe depression)
  • Less than 6 months life expectancy
  • Alcohol abuse or dependence

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Low-income status
  • Documented diagnosis of T1D
  • 18 years of age or older
  • Federally Qualified Health Center (FQHC) primary care provider
  • English or Spanish-speaking And at intervention sites
  • Willingness to wear a CGM sensor
  • Adult family member or friend, who will give consent to participate in the study and co-attend the 4-week intervention sessions
  • Reported difficulty in using CGM if current or past use of CGM

Who cannot take part

  • Serious illness that may prevent study participation (e.g., severe depression)
  • Uncorrected hearing or vision impairment
  • Pregnancy or planning to become pregnant
  • Lactation
  • Less than 6 months life expectancy
  • Alcohol abuse or dependence

Where in United States

  • Community Health Center, Inc.Middletown, United StatesEnrolling by invitation
  • Treasure Coast Community HealthVero Beach, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Low-income adults with type 1 diabetes (T1D), despite their disproportionate burden of acute complications (hypoglycemia and diabetes ketoacidosis) and related emergency department visits, hospitalizations, and death, remain largely disenfranchised from continuous glucose monitoring (CGM), an efficacious technology to mitigate these inequities. To increase CGM uptake in low-income, adults with T1D receiving diabetes management in federally qualified health centers (FQHCs), this pilot randomized control trial (RCT), will assess the feasibility of our study protocol, including our multi-level intervention informed by the Socio-Ecological Model.

The 2 groups in the trial

  • Continuous Glucose Monitoring (CGM) Intervention ArmTreatment being tested

    The intervention arm comprises participants receiving care from FQHC sites randomized to deliver the intervention. This arm will receive the 6-month, SEM-informed intervention to promote CGM uptake and maintenance.

    Treatment: CGM Intervention

  • Self-Monitoring of Blood Glucose (SMBG) ArmOther group

    The SMBG control arm comprises participants receiving care from FQHC sites randomized to deliver the control condition. This arm will receive the 6-month control condition.

    Treatment: SMBG Control Condition

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D
Plain-language title
Helping low-income adults with type 1 diabetes start continuous glucose monitoringGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
12 August 2025